4-hydroxyantipyrine has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belwon, S; Dengler, HJ; Edeki, T; Funke, C; Lindecken, KD; Robertz-Vaupel, GM | 1 |
| Imai, Y; Inada, M; Inui, Y; Ito, N; Kawata, S; Matsuda, Y; Miyoshi, S; Noda, S; Saitoh, R; Tamura, S | 1 |
2 other study(ies) available for 4-hydroxyantipyrine and Liver Neoplasms
| Article | Year |
|---|---|
Disposition of antipyrine in patients with extensive metastatic liver disease.
Topics: Adenocarcinoma; Aged; Antipyrine; Colorectal Neoplasms; Edaravone; Female; Humans; Liver Neoplasms; Male; Middle Aged | 1992 |
[Alterations of urinary excretion of antipyrine metabolites in patients with cirrhosis of the liver].
Topics: Antipyrine; Carcinoma, Hepatocellular; Edaravone; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 1987 |